PT Maja Agung Latexindo (SURI) Fundamentals 2026 — P/E 2233.3x, Revenue Analysis | SniperIQ
PT Maja Agung Latexindo (SURI) is a ID-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of Rp424.4B, trading at Rp67.00 on the JKT. This SniperIQ fundamentals page covers PT Maja Agung Latexindo's valuation (P/E 2233.3x, P/B 1.2x), profitability (net margin -0.1%), revenue (Rp150.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Maja Agung Latexindo's market cap?
PT Maja Agung Latexindo (SURI) has a market capitalization of approximately Rp424.4B, trading at Rp67.00 on the JKT. Market cap moves with the live share price.
What is PT Maja Agung Latexindo's P/E ratio?
PT Maja Agung Latexindo's trailing twelve-month P/E ratio is 2233.3x, with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT Maja Agung Latexindo?
PT Maja Agung Latexindo runs a net profit margin of -0.1%, a gross margin of 8.4%, and an operating margin of 0.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Maja Agung Latexindo generate?
PT Maja Agung Latexindo reported revenue of Rp150.2B for fiscal year 2025, with net income of -Rp3.4B and earnings per share (EPS) of -0.53. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Maja Agung Latexindo pay a dividend?
PT Maja Agung Latexindo does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is PT Maja Agung Latexindo financially healthy?
PT Maja Agung Latexindo carries a debt-to-equity ratio of 0.00x and a current ratio of 5.00x, with a market beta of -0.89. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Maja Agung Latexindo a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Maja Agung Latexindo (SURI) the key facts are: market cap Rp424.4B, P/E 2233.3x, revenue Rp150.2B, 52-week range 50-152. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT Maja Agung Latexindo's full fundamentals live
Get PT Maja Agung Latexindo's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.